Back to Search
Start Over
Exhaustive single nucleotide polymorphism (SNP) analysis of DPYD exome in breast cancer patients (pts) receiving capecitabine
- Source :
- ASCO 2015 annual meeting, ASCO 2015 annual meeting, May 2015, Chicago, IL, United States. pp.abstr 2571, ASCO 2015 annual meeting, May 2015, Chicago, IL, United States. 33 (15 suppl), pp.abstr 2571, 2015, Journal of Clinical Oncology
- Publication Year :
- 2015
- Publisher :
- HAL CCSD, 2015.
-
Abstract
- published in Journal of Clinical Oncology, 33(15-Suppl):2571, 2015. Poster Session, Developmental Therapeutics - Clinical Pharmacology and Experimental Therapeutics. Abstract Number: 2571. Poster Board Number: #287; International audience
- Subjects :
- Cancer Research
business.industry
education
Single-nucleotide polymorphism
Bioinformatics
medicine.disease
3. Good health
Capecitabine
Breast cancer
Oncology
[ SDV.BBM.GTP ] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN]
[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN]
Medicine
[SDV.BBM.GTP] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN]
DPYD
business
Prospective cohort study
Exome
human activities
health care economics and organizations
SNP array
medicine.drug
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- ASCO 2015 annual meeting, ASCO 2015 annual meeting, May 2015, Chicago, IL, United States. pp.abstr 2571, ASCO 2015 annual meeting, May 2015, Chicago, IL, United States. 33 (15 suppl), pp.abstr 2571, 2015, Journal of Clinical Oncology
- Accession number :
- edsair.doi.dedup.....0ac09ef577258df9081f42d55a5f3381